Nephrogenic systemic fibrosis in Denmark--a nationwide investigation. - Wikidata - awgldk - TriplyDB

Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.

Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.

http://www.wikidata.org/entity/Q35069926

about

Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.Safety and efficacy of gadoteric acid in pediatric magnetic resonance imaging: overview of clinical trials and post-marketing studies.Gadolinium-based contrast agents: A comprehensive risk assessment.

P2860

Q30930526-623400E2-6B67-4DC7-A4D5-56C368D0E0F3 Q38516664-70EC8295-50A5-4FC3-BC0C-10E23A26090C Q39022872-C0707C41-337C-4DC0-9BDC-23BFD22A673A

P2860

Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.

http://www.wikidata.org/entity/Q35069926

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.

@ast

Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.

@en

type

label

Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.

@ast

Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.

@en

prefLabel

Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.

@ast

Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.

@en

P1433

Q35069926-216BFE68-21C2-41DE-86C1-D35809884598

P1476

Q35069926-7FB338B1-B433-4C4B-96CB-A49B9B7343BE

P2093

Q35069926-198A5B8F-CD99-4CC9-901B-774580D05F60

Q35069926-1CCF05C9-767F-4BDE-BF70-8D0B56CD75FE

Q35069926-2B13FA67-0E4F-47CB-AB03-11FB48F58F89

Q35069926-2BFDF841-EDA2-4410-B425-1AC00FDAB7C1

Q35069926-55487AB5-54E0-4ADA-AEF3-B3998E514B5F

Q35069926-C0814327-4B1D-44E3-BCD8-D11E1D5FF2FD

Q35069926-CB28862E-A3F1-4C7A-BD40-B6BAC8FD0A0C

P2860

Q35069926-0AEED876-617D-4216-9356-2FAC62B0935F

Q35069926-12F61AC1-0520-4330-838F-19DC3C582017

Q35069926-1EC6F414-759B-44FF-9ED1-918BA62A8826

Q35069926-2E99BC2E-FB0E-45B1-B404-BA442BC37BAA

Q35069926-3FFA5BEC-08A7-41A1-80BB-891B87EA7072

Q35069926-56F1710B-DE84-4B5C-960B-E7A7089EBD32

Q35069926-5C20026F-3910-42B7-B94D-A87E1158AFE3

Q35069926-63FE72B4-3A03-4756-992F-7B19CFA9B0DD

Q35069926-72ACFEAE-E0D9-4C4D-89CC-192FF4B4F8BF

Q35069926-72D9E90B-B987-405F-8D1D-3C1CBEC824D6

P304

Q35069926-DA4F9498-E520-4F0A-BDCC-6C597896411E

P31

Q35069926-4A06EA24-C800-424A-88B5-D15B3DDA2F98

P356

Q35069926-73091E35-D80E-4FF7-A5B9-FEE65A7B2BEE

P407

Q35069926-C350127C-F7D5-4035-A0E2-175D26D68A9D

P433

Q35069926-4EE0A08A-FD57-4049-A92B-639661956270

P478

Q35069926-F655EB77-F557-46CB-8848-66592763B19D

P50

Q35069926-A8EA9799-9294-49C1-9945-2A60CDE0FF33

P577

Q35069926-D68079EE-C117-4365-A820-9611477B1D1C

P5875

Q35069926-33EA40CF-1A71-4012-B438-84056E9B095F

P698

Q35069926-F2410B75-BFA3-4F71-9AE1-81BD69F34429

P932

Q35069926-348895F4-B2D1-49B8-8F1E-EBBE84E6015A

P356

JOURNAL.PONE.0082037

P1433

P1476

Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.

@en

P2093

Anne B B Olesen

http://www.w3.org/2001/XMLSchema#string

Bettina Jørgensen

http://www.w3.org/2001/XMLSchema#string

Henrik S Thomsen

http://www.w3.org/2001/XMLSchema#string

Michael Pedersen

http://www.w3.org/2001/XMLSchema#string

Peter Marckmann

http://www.w3.org/2001/XMLSchema#string

Stinne Kvist

http://www.w3.org/2001/XMLSchema#string

Tina R Elmholdt

http://www.w3.org/2001/XMLSchema#string

P2860

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness

Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006.

Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).

Clinical and histological findings in nephrogenic systemic fibrosis.

Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases

Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine.

P304

e82037

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0082037

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259355036

http://www.w3.org/2001/XMLSchema#string

P698

24349178

http://www.w3.org/2001/XMLSchema#string

P932

3857209

http://www.w3.org/2001/XMLSchema#string